New prostate cancer scanning a ‘game-changer’

Thursday 13th June 2019

A technique that allows for more accurate diagnosis of possible prostate cancer relapse is to be rolled out to four centres across Scotland.  

Gallium scanning technology will be funded by NHS Scotland and allows clinicians to identify exactly where any follow-up tumours are located, allowing for appropriate treatment.

The scanning will be located in NHS Greater Glasgow & Clyde, NHS Tayside, NHS Lothian and NHS Grampian.

The project will be backed by £2m and contracts have been awarded to allow the procurement of the equipment required.

The service is expected to be operational around spring 2020.

Making the announcement during men’s health week, Jeane Freeman, Cabinet Secretary for Health & Sport said:

“Prostate cancer is the most common male cancer in Scotland, so it’s vital that we ensure that the best treatment is available.

“This equipment will allow clinicians to get quick and accurate information about whether advanced prostate cancer has spread to another part of the body. If there is no spread, the patient can be reassured, and if there are additional tumours, the medical team can put the right treatment in place.”

Dr Roger Staff, PET/CT lead for the Scottish clinical imaging network, said:

“The introduction of this service represents a marked service development that will significantly improve the management of prostate and neuroendocrine cancer in Scotland.

“This is not only a ‘game changer’ for patients with prostate cancer, but the installation of the infrastructure required will future-proof centres and allow new techniques to be introduced faster.”